
Prince Akwasi Mensah
Examiner (ID: 16550, Phone: (571)270-7183 , Office: P/2474 )
| Most Active Art Unit | 2474 |
| Art Unit(s) | 2416, 2474 |
| Total Applications | 590 |
| Issued Applications | 431 |
| Pending Applications | 63 |
| Abandoned Applications | 119 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 3533436
[patent_doc_number] => 05556844
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-09-17
[patent_title] => 'Pharmaceutical or cosmetic composition containing a combination of a retinoid and a sterol'
[patent_app_type] => 1
[patent_app_number] => 7/962596
[patent_app_country] => US
[patent_app_date] => 1993-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8665
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/556/05556844.pdf
[firstpage_image] =>[orig_patent_app_number] => 962596
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/962596 | Pharmaceutical or cosmetic composition containing a combination of a retinoid and a sterol | Mar 1, 1993 | Issued |
| 08/023226 | PROTEASE INHIBITING COMPOUNDS | Feb 24, 1993 | Abandoned |
Array
(
[id] => 3078342
[patent_doc_number] => 05321022
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-06-14
[patent_title] => 'Compositions for percutaneous administration'
[patent_app_type] => 1
[patent_app_number] => 8/022382
[patent_app_country] => US
[patent_app_date] => 1993-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2143
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/321/05321022.pdf
[firstpage_image] =>[orig_patent_app_number] => 022382
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/022382 | Compositions for percutaneous administration | Feb 23, 1993 | Issued |
Array
(
[id] => 3525099
[patent_doc_number] => 05504068
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-04-02
[patent_title] => 'Topical preparations containing cyclosporin'
[patent_app_type] => 1
[patent_app_number] => 7/975548
[patent_app_country] => US
[patent_app_date] => 1993-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8911
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/504/05504068.pdf
[firstpage_image] =>[orig_patent_app_number] => 975548
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/975548 | Topical preparations containing cyclosporin | Feb 22, 1993 | Issued |
Array
(
[id] => 3098955
[patent_doc_number] => 05314881
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-05-24
[patent_title] => 'Use of phosphomycin and the pharmaceutically acceptable salts thereof as a topical cicatrizer'
[patent_app_type] => 1
[patent_app_number] => 8/019345
[patent_app_country] => US
[patent_app_date] => 1993-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1360
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/314/05314881.pdf
[firstpage_image] =>[orig_patent_app_number] => 019345
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/019345 | Use of phosphomycin and the pharmaceutically acceptable salts thereof as a topical cicatrizer | Feb 17, 1993 | Issued |
Array
(
[id] => 2994649
[patent_doc_number] => 05366982
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-11-22
[patent_title] => 'Substituted bicyclic bis-aryl compounds exhibiting selective leukotriene B.sub.4 antagonist activity, their preparation and use in pharmaceutical compositions'
[patent_app_type] => 1
[patent_app_number] => 7/966151
[patent_app_country] => US
[patent_app_date] => 1993-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26684
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 366
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/366/05366982.pdf
[firstpage_image] =>[orig_patent_app_number] => 966151
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/966151 | Substituted bicyclic bis-aryl compounds exhibiting selective leukotriene B.sub.4 antagonist activity, their preparation and use in pharmaceutical compositions | Feb 16, 1993 | Issued |
Array
(
[id] => 3044724
[patent_doc_number] => 05334594
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-08-02
[patent_title] => 'Amphoteric tricyclic compound'
[patent_app_type] => 1
[patent_app_number] => 8/015812
[patent_app_country] => US
[patent_app_date] => 1993-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14578
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/334/05334594.pdf
[firstpage_image] =>[orig_patent_app_number] => 015812
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/015812 | Amphoteric tricyclic compound | Feb 9, 1993 | Issued |
Array
(
[id] => 3427730
[patent_doc_number] => 05403817
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-04-04
[patent_title] => 'Arylaminocarbonyl compounds'
[patent_app_type] => 1
[patent_app_number] => 8/013555
[patent_app_country] => US
[patent_app_date] => 1993-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9862
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 625
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/403/05403817.pdf
[firstpage_image] =>[orig_patent_app_number] => 013555
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/013555 | Arylaminocarbonyl compounds | Feb 4, 1993 | Issued |
Array
(
[id] => 3457046
[patent_doc_number] => 05378848
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-01-03
[patent_title] => 'Condensed imidazopyridine derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/012424
[patent_app_country] => US
[patent_app_date] => 1993-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14586
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 276
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/378/05378848.pdf
[firstpage_image] =>[orig_patent_app_number] => 012424
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/012424 | Condensed imidazopyridine derivatives | Feb 1, 1993 | Issued |
Array
(
[id] => 3115021
[patent_doc_number] => 05395937
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-03-07
[patent_title] => 'Process for preparing quinoline amines'
[patent_app_type] => 1
[patent_app_number] => 8/011405
[patent_app_country] => US
[patent_app_date] => 1993-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5048
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/395/05395937.pdf
[firstpage_image] =>[orig_patent_app_number] => 011405
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/011405 | Process for preparing quinoline amines | Jan 28, 1993 | Issued |
Array
(
[id] => 3407794
[patent_doc_number] => 05460832
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-10-24
[patent_title] => 'Skin cosmetic having an egg white enzyme hydrolysate with hyaluronic acid synthesis promoting activity'
[patent_app_type] => 1
[patent_app_number] => 8/010877
[patent_app_country] => US
[patent_app_date] => 1993-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4332
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/460/05460832.pdf
[firstpage_image] =>[orig_patent_app_number] => 010877
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/010877 | Skin cosmetic having an egg white enzyme hydrolysate with hyaluronic acid synthesis promoting activity | Jan 28, 1993 | Issued |
Array
(
[id] => 3099394
[patent_doc_number] => 05314902
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-05-24
[patent_title] => 'Urea derivatives useful as platelet aggregation inhibitors'
[patent_app_type] => 1
[patent_app_number] => 8/009526
[patent_app_country] => US
[patent_app_date] => 1993-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10513
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/314/05314902.pdf
[firstpage_image] =>[orig_patent_app_number] => 009526
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/009526 | Urea derivatives useful as platelet aggregation inhibitors | Jan 26, 1993 | Issued |
Array
(
[id] => 2894863
[patent_doc_number] => 05272170
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-12-21
[patent_title] => 'Tetralones with pharmacological activity'
[patent_app_type] => 1
[patent_app_number] => 8/006852
[patent_app_country] => US
[patent_app_date] => 1993-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31719
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/272/05272170.pdf
[firstpage_image] =>[orig_patent_app_number] => 006852
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/006852 | Tetralones with pharmacological activity | Jan 21, 1993 | Issued |
Array
(
[id] => 2937763
[patent_doc_number] => 05247090
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-09-21
[patent_title] => 'Tricyclic [6,6,5]-fused oxazolidinone antibacterial agents'
[patent_app_type] => 1
[patent_app_number] => 8/006596
[patent_app_country] => US
[patent_app_date] => 1993-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15840
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/247/05247090.pdf
[firstpage_image] =>[orig_patent_app_number] => 006596
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/006596 | Tricyclic [6,6,5]-fused oxazolidinone antibacterial agents | Jan 20, 1993 | Issued |
Array
(
[id] => 2934817
[patent_doc_number] => 05246940
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-09-21
[patent_title] => 'Substituted N-biphenylyl lactams'
[patent_app_type] => 1
[patent_app_number] => 8/006591
[patent_app_country] => US
[patent_app_date] => 1993-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8900
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/246/05246940.pdf
[firstpage_image] =>[orig_patent_app_number] => 006591
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/006591 | Substituted N-biphenylyl lactams | Jan 20, 1993 | Issued |
Array
(
[id] => 3095823
[patent_doc_number] => 05290942
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-03-01
[patent_title] => 'Quaternary pyridinium compounds and uses therefor'
[patent_app_type] => 1
[patent_app_number] => 8/006367
[patent_app_country] => US
[patent_app_date] => 1993-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22054
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 252
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/290/05290942.pdf
[firstpage_image] =>[orig_patent_app_number] => 006367
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/006367 | Quaternary pyridinium compounds and uses therefor | Jan 18, 1993 | Issued |
| 08/004238 | COMPOSITION FOR ACCELERATING WOUND HEALING | Jan 13, 1993 | Abandoned |
Array
(
[id] => 2992255
[patent_doc_number] => 05347006
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-09-13
[patent_title] => 'Method of preparing a polymorph of terfenadine'
[patent_app_type] => 1
[patent_app_number] => 7/999596
[patent_app_country] => US
[patent_app_date] => 1992-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2363
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/347/05347006.pdf
[firstpage_image] =>[orig_patent_app_number] => 999596
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/999596 | Method of preparing a polymorph of terfenadine | Dec 30, 1992 | Issued |
| 07/996694 | TRICYCLIC COMPOUNDS | Dec 23, 1992 | Abandoned |
Array
(
[id] => 3475586
[patent_doc_number] => 05428042
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-06-27
[patent_title] => '1-(2H-1-oxo-3,4-dihydronaphtyl-6-yl)-acetyl-piperidines as kappa agonists'
[patent_app_type] => 1
[patent_app_number] => 7/940858
[patent_app_country] => US
[patent_app_date] => 1992-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8548
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/428/05428042.pdf
[firstpage_image] =>[orig_patent_app_number] => 940858
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/940858 | 1-(2H-1-oxo-3,4-dihydronaphtyl-6-yl)-acetyl-piperidines as kappa agonists | Dec 22, 1992 | Issued |